EE145 Real-World Healthcare Resource Use, Costs, and Treatment Patterns in Advanced or Metastatic Non-Small Cell Lung Cancer Patients with Different Epidermal Growth Factor Receptor Mutation Types
Vadagam, P., Chen, J., Lee, I., Tian, D., Waters, D.D., Near, A., Lyle, D., Vanderpoel, J.
Published in Value in health (01.06.2023)
Published in Value in health (01.06.2023)
Get full text
Journal Article
EE274 Estimated Costs of Adverse Event Management in NSCLC Patients with Epidermal Growth Factor Receptor Exon 20 Insertion Mutations Treated with Amivantamab or Mobocertinib after Progression on Platinum-Based Chemotherapy
Vadagam, P, Vanderpoel, J, Khan, A, Malek, M, Musci, R, Zou, D
Published in Value in health (01.07.2022)
Published in Value in health (01.07.2022)
Get full text
Journal Article
EE230 Clinical and Economic Outcomes Associated With Use of Anti-Arrhythmic Drugs Versus Ablation in Atrial Fibrillation (AFib)
Ken-Opurum, J, Vadagam, P, Faith, L, Srinivas, SSS, Preblick, R, Park, S, Charland, S, Revel, A
Published in Value in health (01.12.2022)
Published in Value in health (01.12.2022)
Get full text
Journal Article
BURDEN OF ILLNESS IN CYSTIC FIBROSIS: A RETROSPECTIVE ANALYSIS OF MEDICAL EXPENDITURE PANEL SURVEY (MEPS) DATA
Vadagam, P, Kamal, KM, Mukherjee, K, Covvey, JR, Giannetti, V
Published in Value in health (01.05.2017)
Get full text
Published in Value in health (01.05.2017)
Journal Article